Faculty

Institution

Unit

Venue

Linda Schuler

Professor

University of Wisconsin–Madison

Affiliations

School of Veterinary Medicine

Comparative Biosciences

School of Medicine and Public Health

Stem Cell and Regenerative Medicine Center

Linda Schuler is currently serving as a Comparative Biosciences Professor at University of Wisconsin–Madison.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Linda Schuler

University of Wisconsin–Madison

Professor

You can click a keyword to filter the displayed items

pharmacology endocrinology cell biology breast cancer medicinal research molecular biology genetics tumor biology cancer research oncology mammalian biology cancer biology gene expression cell signaling cancer cells endocrine research molecular physiology endocrine oncology cancer genomics molecular cancer cancer treatment signal transduction mammary gland vascular biology reproductive biology protein science matrix biology cancer care cancer imaging cell regulation tumor targeting reproductive science oncogenes cellular therapy comparative endocrinology cancer genetics cancer growth breast cancer cells breast oncology animal biotechnology animal physiology signaling pathways cytokines reproductive physiology endocrine mechanisms growth hormone receptor (biochemistry) endocrine-related cancers radiation therapy in vivo systems female reproductive system receptor tyrosine kinases protein function animal reproduction placental development endocrine diseases rna biology endocrine disruptors experimental pathology clinical pathology cancer risk molecular cloning placental lactogen transgenic mice prolactin receptor heterogeneity prolactin signals mammary neoplasia estrogen receptor blockade biological implications mammary carcinoma prolactin induces era-negative mammary cancer prolactin receptor ovine endometrium estrous cycle prolactin-induced estrogen receptor gynecology

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract Po4-24-07: The Impact of Gper Modulation on Cancer Associated Fibroblasts on Extracellular Matrix Formation in Breast Cancer. Cancer Research (2024)

Shelby FertalBrian BurkelFern MurdochKathy O'LearyLinda SchulerSuzanne Ponik

cancer biologyleukemiapharmacologyurologytumor biologycancer researchoncologygper modulationcancer carecancer treatmentcancer genomicsradiation oncologyextracellular matrix formationbreast cancermedicinal researchcancer imagingcancer growthcancer cellscancer managementprostate cancer

Data From Antiestrogen Therapy Increases Plasticity and Cancer Stemness of Prolactin-Induced Erα Sup + /Sup Mammary Carcinomas. (2023)

Michael P. SheaKathleen A. O'LearySaja A. FakhraldeenVincent GoffinAndreas FriedlKari B. WisinskiCaroline M. AlexanderLinda A. Schuler

cancer biologybreast oncologypharmacologyendocrine oncologymetastasistumor biologycellular therapycancer researchoncologymedical mycologycancer treatmentneurologygenitourinary cancersantiestrogen therapycancer stemnessbreast cancergynecologic oncologymedicinal researchcancer imaginghealth sciences

Estrogen Receptor Blockade and Radiation Therapy Cooperate to Enhance the Response of Immunologically Cold Er+ Breast Cancer to Immunotherapy. Breast Cancer Research (2023)

Kathleen A. O’LearyAmber M. BatesWon Jong JinBrian M. BurkelRaghava N. SriramaneniSarah E. EmmaErin J. NystuenElizabeth G. SumiecSuzanne M. PonikZachary S. MorrisLinda A. Schuler

cancer immunotherapymedicineradiation therapyoncologyradiation oncologycancer researchcancer biologyestrogen receptor blockadeimmunotherapycancer treatmenthealth sciencesbreast cancer

Supplemental Tables From Antiestrogen Therapy Increases Plasticity and Cancer Stemness of Prolactin-Induced Erα Sup + /Sup Mammary Carcinomas. (2023)

Michael P. SheaKathleen A. O'LearySaja A. FakhraldeenVincent GoffinAndreas FriedlKari B. WisinskiCaroline M. AlexanderLinda A. Schuler

antiestrogen therapylineage plasticitycancer stemnessoncology

Multifunctional Nanoparticle Potentiates the in Situ Vaccination Effect of Radiation Therapy and Enhances Response to Immune Checkpoint Blockade. Nature Communications (2022)

Ying ZhangRaghava N. SriramaneniPaul A. ClarkJustin C. JagodinskyMingzhou YeWonjong JinYuyuan WangAmber BatesCaroline P. KerrTrang LeRaad AllawiXiuxiu WangRuosen XieThomas C. HavighurstIshan ChakravartyAlexander L. RakhmilevichKathleen A. O’LearyLinda A. SchulerPaul M. SondelKyungmann KimShaoqin GongZachary S. Morris

cancer immunotherapymedicineradiation therapynanobiotechnologynanomaterialshost responseenhances responseimmunologynanomedicinenanoparticle researchhealth sciencesmultifunctional nanoparticlenanotechnology

PROLACTIN: The Third Hormone in Breast Cancer. Frontiers in Endocrinology (2022)

Linda A. SchulerKathleen A. O’Leary

endocrinologyhealth sciencesthird hormonebreast cancer

Superior Stimulation of β-Casein Mrna Accumulation by Pseudophosphorylated Prolactin: Enhanced Transcription and Message Stabilization. IntechOpen eBooks (2022)

Wei WuChanghui DengJennifer L. BrockmanLinda A. SchulerAmeae M. Walker

protein sciencepharmacologymammalian biologygene expressionsmall rnab-casein mrna accumulationknockout miceopen researchmembrane biologygeneticsprotein biosynthesissuperior stimulationmessage stabilizationtranscription (biology)transcription factorspseudophosphorylated prolactinnucleic acidsactive controlsignal transductiontranscription regulationmolecular biologyenzyme inhibition

Abstract 676: Fulvestrant and Radiation Modify the Tumor Immune Microenvironment in Er+ Metastatic Breast Cancer and Cooperate to Enhance Response to Anti-Pdl1 Checkpoint Blockade. Cancer Research (2021)

Erin J. NystuenAmber M. BatesKathleen A. O'LearySarah E. EmmaElizabeth G. SumiecLinda A. SchulerZachary S. Morris

cancer immunotherapymedicineradiation therapycancer biologyradiationpharmacologycellular therapycancer researchoncologycancer carecancer treatmenttumor microenvironmentradiation oncologytumor targetingtumor immune microenvironmentmedicinal researchsurgical oncologycancer imagingcancer management

Endogenous and Therapeutic Estrogens: Maestro Conductors of the Microenvironment of Er+ Breast Cancers. Cancers (2021)

Linda A. SchulerFern E. Murdoch

cancer biologybreast oncologypharmacologyendocrine oncologyurologycancer researchoncologymaestro conductorsendocrine disruptorscancer careneurologytumor microenvironmentendocrine researchtherapeutic estrogensvascular biologybreast cancermedicinal researchcancer imagingendocrinologycancer cells

Prolactin Synergizes With Canonical Wnt Signals to Drive Development of Er+ Mammary Tumors via Activation of the Notch Pathway. Cancer Letters (2021)

Kathleen A. O'LearyDebra E. RugowskiMichael P. SheaRuth SullivanAmy R. MoserLinda A. Schuler

cancer lettermedicinepharmacologycanonical wnt signalscarcinogenesismetastasisnotch pathwaycancer carecancer treatmentcancer riskmolecular cancerneuro-oncologytumor targetingbreast cancersignaling pathwayscancer imagingcancer cellslymphocyte developmentsignal transductionhealth sciences

1
2
3
4
5
11
10 / page

Linda Schuler

Professor

University of Wisconsin–Madison

Affiliations

School of Veterinary Medicine

Comparative Biosciences

School of Medicine and Public Health

Stem Cell and Regenerative Medicine Center

Linda Schuler is currently serving as a Comparative Biosciences Professor at University of Wisconsin–Madison.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Linda Schuler

University of Wisconsin–Madison

Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract Po4-24-07: The Impact of Gper Modulation on Cancer Associated Fibroblasts on Extracellular Matrix Formation in Breast Cancer. Cancer Research (2024)

Shelby FertalBrian BurkelFern MurdochKathy O'LearyLinda SchulerSuzanne Ponik

Data From Antiestrogen Therapy Increases Plasticity and Cancer Stemness of Prolactin-Induced Erα Sup + /Sup Mammary Carcinomas. (2023)

Michael P. SheaKathleen A. O'LearySaja A. FakhraldeenVincent GoffinAndreas FriedlKari B. WisinskiCaroline M. AlexanderLinda A. Schuler

Estrogen Receptor Blockade and Radiation Therapy Cooperate to Enhance the Response of Immunologically Cold Er+ Breast Cancer to Immunotherapy. Breast Cancer Research (2023)

Kathleen A. O’LearyAmber M. BatesWon Jong JinBrian M. BurkelRaghava N. SriramaneniSarah E. EmmaErin J. NystuenElizabeth G. SumiecSuzanne M. PonikZachary S. MorrisLinda A. Schuler

cancer immunotherapymedicineradiation therapyoncologyradiation oncologycancer researchcancer biologyestrogen receptor blockadeimmunotherapycancer treatmenthealth sciencesbreast cancer

Supplemental Tables From Antiestrogen Therapy Increases Plasticity and Cancer Stemness of Prolactin-Induced Erα Sup + /Sup Mammary Carcinomas. (2023)

Michael P. SheaKathleen A. O'LearySaja A. FakhraldeenVincent GoffinAndreas FriedlKari B. WisinskiCaroline M. AlexanderLinda A. Schuler

antiestrogen therapylineage plasticitycancer stemnessoncology

Multifunctional Nanoparticle Potentiates the in Situ Vaccination Effect of Radiation Therapy and Enhances Response to Immune Checkpoint Blockade. Nature Communications (2022)

PROLACTIN: The Third Hormone in Breast Cancer. Frontiers in Endocrinology (2022)

Linda A. SchulerKathleen A. O’Leary

endocrinologyhealth sciencesthird hormonebreast cancer

Superior Stimulation of β-Casein Mrna Accumulation by Pseudophosphorylated Prolactin: Enhanced Transcription and Message Stabilization. IntechOpen eBooks (2022)

Wei WuChanghui DengJennifer L. BrockmanLinda A. SchulerAmeae M. Walker

Erin J. NystuenAmber M. BatesKathleen A. O'LearySarah E. EmmaElizabeth G. SumiecLinda A. SchulerZachary S. Morris

Endogenous and Therapeutic Estrogens: Maestro Conductors of the Microenvironment of Er+ Breast Cancers. Cancers (2021)

Linda A. SchulerFern E. Murdoch

Prolactin Synergizes With Canonical Wnt Signals to Drive Development of Er+ Mammary Tumors via Activation of the Notch Pathway. Cancer Letters (2021)

Kathleen A. O'LearyDebra E. RugowskiMichael P. SheaRuth SullivanAmy R. MoserLinda A. Schuler

1
2
3
4
5
11
10 / page

Similar Faculty Members

Ruth Keri

Institution

Case Western Reserve University

breast cancer

oncology

Larry Suva

Institution

Texas A&M University

orthopaedic surgery

health science

Alan Wells

Institution

University of Pittsburgh

stem cell

stem-cell therapy

George Michalopoulos

Institution

University of Pittsburgh

liver regeneration

carcinogenesis

Shuk-Mei Ho, PhD

Institution

University of Cincinnati

endocrine disruption

endocrinology

Joel S. Greenberger

Institution

University of Pittsburgh

cancer letter

pathology

Thomas J. Rosol

Institution

Ohio University

cancer risk

bone pathology

Kermit Carraway

Institution

University of California, Davis

pharmacological research

toxicological mechanism

Gail Sonenshein

Institution

Tufts University

cancer risk

nf-�b family

Cheryl Walker, Ph.D.

Institution

Baylor College of Medicine

molecular metabolism

epigenetics

Similar Faculty Members

Ruth Keri

Institution

Case Western Reserve University

breast cancer

oncology

Larry Suva

Institution

Texas A&M University

orthopaedic surgery

health science

Alan Wells

Institution

University of Pittsburgh

stem cell

stem-cell therapy

George Michalopoulos

Institution

University of Pittsburgh

liver regeneration

carcinogenesis

Shuk-Mei Ho, PhD

Institution

University of Cincinnati

endocrine disruption

endocrinology

Joel S. Greenberger

Institution

University of Pittsburgh

cancer letter

pathology

Thomas J. Rosol

Institution

Ohio University

cancer risk

bone pathology

Kermit Carraway

Institution

University of California, Davis

pharmacological research

toxicological mechanism

Gail Sonenshein

Institution

Tufts University

cancer risk

nf-�b family

Cheryl Walker, Ph.D.

Institution

Baylor College of Medicine

molecular metabolism

epigenetics